Drug metabolism in NADPH fortified rat liver microsomes assessed as N-((4-(4-fluorophenyl)-2-oxochroman-7-yl)methyl)-2-((S)-2-hydroxy-2-(trifluorometh...

Basic Information

ID: ALA3530466

Type: ADME

Description: Drug metabolism in NADPH fortified rat liver microsomes assessed as N-((4-(4-fluorophenyl)-2-oxochroman-7-yl)methyl)-2-((S)-2-hydroxy-2-(trifluoromethyl)butanoyl)hydrazinecarboxamide level

Format: BAO_0000019

Organism: Rattus norvegicus

Tissue: Liver

Target: Liver microsome(ALA2367428)

Document: ALA3526019

Drug metabolism in NADPH fortified rat liver microsomes assessed as N-((4-(4-fluorophenyl)-2-oxochroman-7-yl)methyl)-2-((S)-2-hydroxy-2-(trifluoromethyl)butanoyl)hydrazinecarboxamide level: 1

Associated Items: Associated Bioactivities Associated Compounds

Activity Charts

Bioactivity

Activity Types for Assay ALA3530466

Drug metabolism

Total(1)

Parent Molecular Weight	ALogP	Polar Surface Area
463.39	4.75	4.75

Parent Molecular Weight

ALogP

Polar Surface Area

463.39

4.75

Drug metabolism in NADPH fortified rat liver microsomes assessed as N-((4-(4-fluorophenyl)-2-oxochroman-7-yl)methyl)-2-((S)-2-hydroxy-2-(trifluorometh...

Basic Information

Activity Charts

Compound Summary